Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
Goal2Quit + NRT Sampling
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Goji berry
United Therapeutics Europe Ltd
Age-Related Macular Degeneration
1 trial -
Goserelin
The First People's Hospital of Lianyungang
Allogeneic Haematopoietic Stem Cell Transplantation
1 trial -
Goserelin 3.6 mg implant
Universal Integrated
Postpartum Depression
1 trial -
Grain-Fed Beef Hamburger
United Therapeutics Europe Ltd
Inflammatory Response
1 trial -
Green Tea Extract
United Therapeutics Europe Ltd
Dysbiosis
1 trial -
Group A (clinical guideline+machine learning)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Guben Kechuan Granules group
Universal Integrated
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
HFMS, MRC, ACTIVLIM, PedsQl-4.0
United Therapeutics Europe Ltd
Flaccid Hemiplegia
1 trial -
HIV self test
United Therapeutics Europe Ltd
HIV Infections
1 trial -
HIV self-testing among female sex workers
United Therapeutics Europe Ltd
Human Immunodeficiency Virus (HIV)
1 trial -
HLA-B*5801 test
BRIGHT MINDS BIOSCIENCES INC.
Stevens-Johnson Syndrome
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
High Dose GGQL Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus, Type 2
1 trial -
High Fat
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
High Fiber Diet Intervention
Universal Integrated
Dietary Fiber
1 trial -
High energy high protein peptide feed study
United Therapeutics Europe Ltd
Malnutrition
1 trial -
High-amylose maize starch+acetate/butyrate
United Therapeutics Europe Ltd
Aerobic Endurance
1 trial -
Home based food
Universal Integrated
Malnutrition, Child
1 trial -
Hou Gu Mi Xi
Universal Integrated
Gastrointestinal Disease
1 trial -
House dust mite
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Allergic Asthma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources